Literature DB >> 11157503

Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura.

G Emilia1, G Longo, M Luppi, G Gandini, M Morselli, L Ferrara, S Amarri, K Cagossi, G Torelli.   

Abstract

Recent reports have suggested an association between Helicobacter pylori infection and idiopathic thrombocytopenic purpura (ITP). The prevalence of H pylori infection and the effect of its eradication in a series of 30 ITP patients were investigated. H pylori infection has been documented in 13 patients (43.33%) by 13C urea breath test and confirmed by histologic examination. Bacterium eradication with antibiotics, obtained in 12 of 13 infected patients (92.3%), led to a complete response in 4 (33.33%) and to a partial response (platelets 90 x 10(9)/L-120 x 10(9)/L) in 2 (16.66%). The response was maintained for a median of 8.33 months, but 1 patient relapsed 7 months after eradication. Search for H pylori infection seems appropriate in ITP patients at diagnosis. Bacterium eradication provides a new good option for a nonimmunosuppressive treatment in some ITP patients.

Entities:  

Mesh:

Year:  2001        PMID: 11157503     DOI: 10.1182/blood.v97.3.812

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

1.  Remission of idiopathic thrombocytopenic purpura by eradicating Helicobacter pylori after omeprazole monotherapy.

Authors:  T Kumagai; K Sekigawa; N Hashimoto; R Shirato
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

Review 2.  Consequences of Helicobacter pylori infection in children.

Authors:  Lucia Pacifico; Caterina Anania; John F Osborn; Flavia Ferraro; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

3.  Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease.

Authors:  Shingo Yamanishi; Tadasu Iizumi; Eri Watanabe; Masumi Shimizu; Shigeru Kamiya; Kumiko Nagata; Yoshihiro Kumagai; Yoshitaka Fukunaga; Hidemi Takahashi
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 4.  Platelets and innate immunity.

Authors:  John W Semple; John Freedman
Journal:  Cell Mol Life Sci       Date:  2009-12-18       Impact factor: 9.261

5.  Immune thrombocytopenic purpura and infections.

Authors:  Antonio Ponzetto; Natale Figura; Giulia Fiorini
Journal:  Intern Emerg Med       Date:  2018-07-20       Impact factor: 3.397

6.  Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and a literature review.

Authors:  Keiko Ando; Takashi Shimamoto; Tetsuzo Tauchi; Yoshikazu Ito; Yuzuru Kuriyama; Akihiko Gotoh; Keisuke Miyazawa; Yukihiko Kimura; Takashi Kawai; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

7.  Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpura.

Authors:  Shannon C Jackson; Paul Beck; Andre G Buret; Pamela M O'Connor; Jonathan Meddings; Graham Pineo; Man-Chiu Poon
Journal:  Int J Hematol       Date:  2008-08-01       Impact factor: 2.490

Review 8.  Refractory idiopathic immune thrombocytopenic purpura in children: current and future treatment options.

Authors:  Paul Imbach
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 9.  Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy.

Authors:  Mitsushige Sugimoto; Yoshio Yamaoka
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-02-14       Impact factor: 4.291

Review 10.  Helicobacter pylori and autoimmune disease: cause or bystander.

Authors:  Daniel S Smyk; Andreas L Koutsoumpas; Maria G Mytilinaiou; Eirini I Rigopoulou; Lazaros I Sakkas; Dimitrios P Bogdanos
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.